Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125334721 | 12533472 | 1 | I | 20120625 | 20160706 | 20160706 | EXP | BR-ABBVIE-12P-020-0949959-00 | ABBVIE | 0.00 | F | Y | 72.00000 | KG | 20160706 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125334721 | 12533472 | 1 | PS | DEPAKENE | VALPROIC ACID | 1 | Oral | U | 040618F01 | 18081 | 500 | MG | TABLET | TID | |||||
| 125334721 | 12533472 | 2 | SS | DEPAKENE | VALPROIC ACID | 1 | Oral | U | 040618F01 | 18081 | 500 | MG | BID | ||||||
| 125334721 | 12533472 | 3 | SS | DEPAKENE | VALPROIC ACID | 1 | Unknown | U | 040618F01 | 18081 | |||||||||
| 125334721 | 12533472 | 4 | SS | DEPAKENE | VALPROIC ACID | 1 | Unknown | U | 040618F01 | 18081 | 250 | MG | BID | ||||||
| 125334721 | 12533472 | 5 | SS | DEPAKENE | VALPROIC ACID | 1 | Unknown | U | 040618F01 | 18081 | |||||||||
| 125334721 | 12533472 | 6 | C | PHENOBARBITAL. | PHENOBARBITAL | 1 | 0 | ||||||||||||
| 125334721 | 12533472 | 7 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | 0 | ||||||||||||
| 125334721 | 12533472 | 8 | C | ATENOLOL. | ATENOLOL | 1 | 0 | ||||||||||||
| 125334721 | 12533472 | 9 | C | CLONAZEPAM. | CLONAZEPAM | 1 | EVENTUALLY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125334721 | 12533472 | 1 | Epilepsy |
| 125334721 | 12533472 | 6 | Product used for unknown indication |
| 125334721 | 12533472 | 7 | Product used for unknown indication |
| 125334721 | 12533472 | 8 | Product used for unknown indication |
| 125334721 | 12533472 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125334721 | 12533472 | HO |
| 125334721 | 12533472 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125334721 | 12533472 | Dengue fever | |
| 125334721 | 12533472 | Eye pain | |
| 125334721 | 12533472 | Generalised erythema | |
| 125334721 | 12533472 | Leukopenia | |
| 125334721 | 12533472 | Lymphocytosis | |
| 125334721 | 12533472 | Monocytosis | |
| 125334721 | 12533472 | Neck mass | |
| 125334721 | 12533472 | Ovarian cyst | |
| 125334721 | 12533472 | Pain | |
| 125334721 | 12533472 | Peripheral swelling | |
| 125334721 | 12533472 | Pneumonia | |
| 125334721 | 12533472 | Post procedural haemorrhage | |
| 125334721 | 12533472 | Pyrexia | |
| 125334721 | 12533472 | Rash macular | |
| 125334721 | 12533472 | Thyroid mass | |
| 125334721 | 12533472 | Unevaluable event |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125334721 | 12533472 | 1 | 1998 | 0 | ||
| 125334721 | 12533472 | 2 | 1998 | 0 | ||
| 125334721 | 12533472 | 3 | 2009 | 0 |